Overview

A Drug-Drug Interaction Study of Digoxin and PA21

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Digoxin is affected by PA21.
Phase:
Phase 1
Details
Lead Sponsor:
Vifor Inc.
Vifor Pharma
Treatments:
Digoxin